ALFA Finder| Revenue growth | FY26 revenue up 21.6% YoY; Q4 up 22.6%. |
|---|---|
| Margins | EBITDA margins improved 31bps to 28.9% in FY26. |
| Demand visibility | Strong; footfalls up 25% to 10,000 patients daily. |
| Management confidence | High; citing disciplined execution and successful greenfield engine scaling. |
Growth
FY26 Revenue rose 21.6% to ₹2,080cr; PAT surged 52.4% to ₹168cr with 7.9% margins.
Outlook
Guidance to commission 60 new facilities in FY27; ₹380-400cr planned capex; targeting Mumbai and North regions.
Risks
Challenges in real estate acquisition and regulatory compliance delays for new facility openings.
Earnings Call filed with BSE, NSE: AGARWALEYE. Summary written with AI assistance from the document.
Dr. Agarwals Health Care Ltd: key numbers
- Share price
- ₹553.60
- Market cap
- ₹17,555 Cr
- Revenue (annual)
- ₹2,080 Cr
- Net profit (annual)
- ₹133.2 Cr
- P/E (TTM)
- 101.2×Sector 54.5×
- Promoter holding
- 32.33%-0.01% QoQ
- FII holding
- 49.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwals Health Care Ltd
All →Dr. Agarwals Health Care Other Announcement
Dr. Agarwal's Health Care submitted ICRA's monitoring agency report for the quarter ended September 30, 2026. ICRA reports no material deviation in IPO proceeds utilisation.
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care allotted 54,728 equity shares to employees on exercise of ESOP 2022 options. Paid-up capital rose to 31,70,99,111 shares, with no cash consideration stated.
Dr. Agarwals Health Care Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%), network-led growth; India EBITDA margin flat near 28%.
Dr. Agarwals Health Care Management Change
Dr Agarwals Health Care reports Mr. Amar Agarwal's redesignation from Chairman and Non-Executive Director to Executive Director, effective 1 November 2026. The change was approved at a board meeting held on 5 November 2026.
Dr. Agarwals Health Care Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%). H1 FY27 revenue ₹1,269 Cr (+28.7%), PAT ₹112 Cr (+50.1%). Strategy is aggressive facility expansion, with 65 FY27E additions.
Dr. Agarwals Health Care Financial Results
Dr. Agarwal's H1 FY27 revenue rose 28.7% to Rs 1,269 crore; PAT rose 50.1% to Rs 112 crore. Amar Agarwal's executive chairman appointment awaits postal ballot approval.